172 related articles for article (PubMed ID: 38683770)
21. New classification system of endometrial hyperplasia WHO 2014 and its clinical implications.
Sobczuk K; Sobczuk A
Prz Menopauzalny; 2017 Sep; 16(3):107-111. PubMed ID: 29507578
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer.
Raffone A; Travaglino A; Saccone G; Cieri M; Mascolo M; Mollo A; Insabato L; Zullo F
APMIS; 2019 Sep; 127(9):597-606. PubMed ID: 31237034
[TBL] [Abstract][Full Text] [Related]
23. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis.
Hecht JL; Ince TA; Baak JP; Baker HE; Ogden MW; Mutter GL
Mod Pathol; 2005 Mar; 18(3):324-30. PubMed ID: 15529181
[TBL] [Abstract][Full Text] [Related]
24. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
25. Reproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran.
Izadi-Mood N; Yarmohammadi M; Ahmadi SA; Irvanloo G; Haeri H; Meysamie AP; Khaniki M
Diagn Pathol; 2009 Mar; 4():10. PubMed ID: 19317919
[TBL] [Abstract][Full Text] [Related]
26. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group.
Mutter GL
Gynecol Oncol; 2000 Mar; 76(3):287-90. PubMed ID: 10684697
[TBL] [Abstract][Full Text] [Related]
27. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Mascolo M; Insabato L; Zullo F
APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
[TBL] [Abstract][Full Text] [Related]
28. Inter-observer reproducibility of endometrial cytology by the Osaki Study Group method: utilising the Becton Dickinson SurePath
Norimatsu Y; Yamaguchi T; Taira T; Abe H; Sakamoto H; Takenaka M; Yanoh K; Yoshinobu M; Irino S; Hirai Y; Kobayashi TK
Cytopathology; 2016 Dec; 27(6):472-478. PubMed ID: 27109167
[TBL] [Abstract][Full Text] [Related]
29. Diagnosing endometrial hyperplasia: why is it so difficult to agree?
Allison KH; Reed SD; Voigt LF; Jordan CD; Newton KM; Garcia RL
Am J Surg Pathol; 2008 May; 32(5):691-8. PubMed ID: 18347507
[TBL] [Abstract][Full Text] [Related]
30. Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma.
Ganesan R; Gilks CB; Soslow RA; McCluggage WG
Int J Gynecol Pathol; 2022 Mar; 41(2):142-150. PubMed ID: 33935157
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical reaction of the glandular epithelium in endometrial hyperplasia compared to endometrial carcinoma.
Stoenescu VE; Niculescu M; Novac L; Manolea MM; Tomescu PI; Dijmărescu AL; Novac MB; Tudorache Ş; Iliescu DG
Rom J Morphol Embryol; 2017; 58(3):791-800. PubMed ID: 29250656
[TBL] [Abstract][Full Text] [Related]
32. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Zaino RJ; Kauderer J; Trimble CL; Silverberg SG; Curtin JP; Lim PC; Gallup DG
Cancer; 2006 Feb; 106(4):804-11. PubMed ID: 16400640
[TBL] [Abstract][Full Text] [Related]
33. International Internet-based assessment of observer variability for diagnostically challenging endometrial biopsies.
Marotti JD; Glatz K; Parkash V; Hecht JL
Arch Pathol Lab Med; 2011 Apr; 135(4):464-70. PubMed ID: 21466363
[TBL] [Abstract][Full Text] [Related]
34. Congruence Between 1994 WHO Classification of Endometrial Hyperplasia and Endometrial Intraepithelial Neoplasia System.
Travaglino A; Raffone A; Saccone G; Mascolo M; Guida M; Mollo A; Insabato L; Zullo F
Am J Clin Pathol; 2020 Jan; 153(1):40-48. PubMed ID: 31433834
[TBL] [Abstract][Full Text] [Related]
35. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
[TBL] [Abstract][Full Text] [Related]
36. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
[TBL] [Abstract][Full Text] [Related]
37. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia.
Salman MC; Usubutun A; Boynukalin K; Yuce K
J Gynecol Oncol; 2010 Jun; 21(2):97-101. PubMed ID: 20613899
[TBL] [Abstract][Full Text] [Related]
38. PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma.
Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrissanthakis D; Yiannou P; Stathopoulos EN
Gynecol Oncol; 2010 Dec; 119(3):516-9. PubMed ID: 20833413
[TBL] [Abstract][Full Text] [Related]
39. Endometrial hyperplasia and the risk of progression to carcinoma.
Lacey JV; Chia VM
Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814
[TBL] [Abstract][Full Text] [Related]
40. Comparison of endometrial cancer risk in patients with endometrial precancerous lesions: WHO 1994 vs EIN classification.
Kender Erturk N; Basaran D; Salman C
J Obstet Gynaecol; 2022 May; 42(4):692-695. PubMed ID: 34415826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
